Topical Nepafenac in Treatment of Acute Central Serous Chorioretinopathy

This study had been performed to investigate the anatomic and functional outcomes of nepafenac 0.1% therapy in acute central serous chorioretinopathy (CSC). The medical records of 30 patients with acute CSC were reviewed for a total of 31 eye charts. Seventeen eye records of 16 patients who were tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkin, Zeynep, Osmanbasoglu, Ozen Ayranci, Ozkaya, Abdullah, Karatas, Gonul, Yazici, Ahmet Taylan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Hypothesis, Discovery & Innovation Ophthalmology 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017634/
https://www.ncbi.nlm.nih.gov/pubmed/24822228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017634/
https://www.ncbi.nlm.nih.gov/pubmed/24822228

Ejemplares similares